MANS‐H constructed in this work demonstrated sufficient stimulation of cDC2 and cross‐presenting CD103+/CD8+ cDC1, which supported the observation of a markedly high magnitude of effector and memory phenotypes of CD8+ T cells and durable humoral immunity, significantly suppressing tumor growth. The gene discussed is CD8A; the disease is neoplasm.